Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Talking gender, ethnicity race, and change: How mothers scaffold girls' identity meaning-making during puberty.

Journal of research on adolescence : the official journal of the Society for Research on Adolescenceยท2026
Same author

Positive Peer Group Affiliation, Puberty, and Social and Emotional Development: A Strength-Based Approach.

Journal of adolescenceยท2026
Same author

Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study.

Cancer research communicationsยท2026
Same author

Drug Delivery Systems for Resiquimod to Control Myeloid-Derived Suppressor Cells in Cancer Immunotherapy.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnologyยท2026
Same author

Erratum: Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Molecular therapy. Nucleic acidsยท2025
Same author

Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Molecular therapy. Nucleic acidsยท2025

Related Experiment Video

Updated: May 12, 2026

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.

Emily Gullotti1, Joonyoung Park, Yoon Yeo

  • 1Weldon School of Biomedical Engineering, Purdue University, 206 South Martin Jischke Drive, West Lafayette, Indiana 47907, USA.

Pharmaceutical Research
|April 24, 2013
PubMed
Summary

Researchers developed smart nanoparticles (NPs) that hide their cell-targeting TAT peptide under a PEG coating until they encounter matrix metalloproteinases (MMPs). This allows targeted drug delivery to cancer cells in MMP-rich environments.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 12, 2026

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) are widely used for drug delivery.
  • Surface modification of NPs can enhance cellular uptake and targeting.
  • Stimuli-responsive materials offer advanced control over drug release and delivery.

Purpose of the Study:

  • To engineer PLGA NPs with a dual-surface modification strategy.
  • To create NPs that present a polyethylene glycol (PEG) surface under normal conditions.
  • To enable NPs to expose a cell-interactive TAT peptide surface in response to matrix metalloproteinases (MMPs).

Main Methods:

  • PLGA NPs were modified using dopamine polymerization.
  • TAT peptide or a TAT peptide-PEG-MMP-substrate conjugate were attached.
  • Cellular uptake was assessed using confocal microscopy and flow cytometry.
  • Paclitaxel (PTX)-loaded NPs were tested for cytotoxicity against SKOV-3 ovarian cancer cells.

Main Results:

  • TAT-modified NPs showed altered surface charge, confirming successful conjugation.
  • Cellular uptake was significantly higher for TAT-containing NPs and MMP-2-activated NPs.
  • PTX-loaded NPs with exposed TAT peptide demonstrated greater cytotoxicity due to enhanced cellular entry.
  • Initial burst drug release influenced the clarity of toxicity differences.

Conclusions:

  • Dual modification of PLGA NPs via dopamine polymerization successfully created stimuli-responsive systems.
  • PEGylated NPs exposed a cell-interactive surface in response to MMP-2.
  • This approach offers a promising strategy for targeted cancer therapy.